The cold sore virus takes over its host’s transcription machinery to replicate itself. Inhibiting a host enzyme can halt ...

Assembly Biosciences is advancing its herpes drug to Phase II trials after it showed 94% antiviral efficacy in a Phase Ib ...

Raipur: The state viral research and diagnostic laboratory (VRDL) at the All India Institute of Medical Sciences (AIIMS), ...

Assembly Biosciences, Inc.'s ABI-5366 showed strong interim phase 1b results in HSV-2 recurrent genital herpes patients.

A 56-year-old woman with a history of relapsed/refractory IgG kappa multiple myeloma presented with a 3-day history of right ...

Assembly Biosciences ( NASDAQ: ASMB) reported promising results from an early stage study of its experimental candidate, ...

Growing research shows common herpes viruses may raise dementia risk, challenging previous skepticism and opening new paths ...

A striking breakthrough in cancer therapy has emerged from an unexpected source: the common herpes simplex virus. A new clinical study has revealed that a genetically engineered version of the herpes ...

Phase 1a clinical data in healthy participants presented for both ABI-5366 and ABI-1179, novel long-acting herpes simplex virus helicase-primase inhibitor candidates – ...

Herpes simplex virus-1 (HSV-1), it turns out, also redecorates, according to a new study in Nature Communications. Researchers at the Centre for Genomic Regulation (CRG) in Barcelona have discovered ...